High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice

被引:11
|
作者
Bao, Jian [1 ,2 ]
Liang, Zheng [1 ]
Gong, Xiaokang [1 ]
Yu, Jing [1 ,2 ]
Xiao, Yifan [1 ,2 ]
Liu, Wei [1 ,2 ]
Wang, Xiaochuan [1 ,3 ]
Wang, Jian-Zhi [1 ,3 ]
Shu, Xiji [1 ,2 ]
机构
[1] Jianghan Univ, Sch Med, Inst Biomed Sci, Wuhan, Peoples R China
[2] Jianghan Univ, Sch Med, Dept Pathol & Pathophysiol, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathophysiol,Key Lab,Minist Educ China Neuro, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; BACE1; high fat; phosphorylation; SUMOylation; ALZHEIMERS-DISEASE; BACE1; TRAFFICKING; TAU; HYPERPHOSPHORYLATION; MECHANISMS; PATHWAYS; DEMENTIA; PROTEINS; DEFICITS;
D O I
10.3233/JAD-215299
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) is the most common form of dementia in older adults and extracellular accumulation of amyloid-beta (A beta) is one of the two characterized pathologies of AD. Obesity is significantly associated with AD developing factors. Several studies have reported that high fat diet (HFD) influenced A beta accumulation and cognitive performance during AD pathology. However, the underlying neurobiological mechanisms have not yet been elucidated. Objective: The objective of this study was to explore the underlying neurobiological mechanisms of HFD influenced A beta accumulation and cognitive performance during AD pathology. Methods: 2.5-month-old male APP/PS1 mice were randomly separated into two groups: 1) the normal diet (ND) group, fed a standard diet (10 kcal% fat); and 2) the HFD group, fed a high fat diet (40 kcal% fat, D12492; Research Diets). After 4 months of HFD orNDfeeding, mice in the two groups were subjected for further ethological, morphological, and biochemical analyses. Results: A long-term HFD diet significantly increased perirenal fat and impaired dendritic integrity and aggravated neurodegeneration, and augmented learning and memory deficits in APP/PS1 mice. Furthermore, the HFD increased beta amyloid cleaving enzyme 1 (BACE1) dephosphorylation and SUMOylation, resulting in enhanced enzyme activity and stability, which exacerbated the deposition of amyloid plaques. Conclusion: Our study demonstrates that long-term HFD consumption aggravates amyloid-beta accumulation and cognitive impairments, and that modifiable lifestyle factors, such as obesity, can induceBACE1post-modifications whichmaycontribute to AD pathogenesis.
引用
收藏
页码:863 / 876
页数:14
相关论文
共 50 条
  • [1] Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice
    Cai, Haobin
    Wang, Yijie
    He, Jiayang
    Cai, Tiantian
    Wu, Jun
    Fang, Jiansong
    Zhang, Rong
    Guo, Zhouke
    Guan, Li
    Zhan, Qinkai
    Lin, Li
    Xiao, Yao
    Pan, Huafeng
    Wang, Qi
    ONCOTARGET, 2017, 8 (54) : 92621 - 92634
  • [2] Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels
    Qing-Shan Deng
    Xing-Yu Dong
    Hao Wu
    Wang Wang
    Zhao-Tao Wang
    Jian-Wei Zhu
    Chun-Feng Liu
    Wei-Qiang Jia
    Yan Zhang
    Melitta Schachner
    Quan-Hong Ma
    Ru-Xiang Xu
    Neuropsychopharmacology, 2016, 41 : 440 - 453
  • [3] Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels
    Deng, Qing-Shan
    Dong, Xing-Yu
    Wu, Hao
    Wang, Wang
    Wang, Zhao-Tao
    Zhu, Jian-Wei
    Liu, Chun-Feng
    Jia, Wei-Qiang
    Zhang, Yan
    Schachner, Melitta
    Ma, Quan-Hong
    Xu, Ru-Xiang
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 (02) : 440 - 453
  • [4] Rapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice
    Jose Ramos-Rodriguez, Juan
    Pacheco-Herrero, Mar
    Thyssen, Diana
    Isabel Murillo-Carretero, Maria
    Berrocoso, Esther
    Spires-Jones, Tara L.
    Bacskai, Brian J.
    Garcia-Alloza, Monica
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (04): : 272 - 285
  • [5] Protective effect of sesamol on cognitive impairment in APP/PS1 mice
    Xu, Y. L.
    Zhang, Y. D.
    Wang, Z. P.
    Chen, W. W.
    Fan, C.
    Xu, J. Q.
    Wang, T.
    Rong, S.
    ACTA ALIMENTARIA, 2023, 52 (02) : 190 - 198
  • [6] Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice
    Lo, Adrian C.
    Callaerts-Vegh, Zsuzsanna
    Nunes, Ana F.
    Rodrigues, Cecilia M. P.
    D'Hooge, Rudi
    NEUROBIOLOGY OF DISEASE, 2013, 50 : 21 - 29
  • [7] Amyloid-β deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice
    Sadowski, M
    Pankiewicz, J
    Scholtzova, H
    Yong, J
    Quartermain, D
    Jensen, CH
    Duff, K
    Nixon, RA
    Gruen, RJ
    Wisniewski, T
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (05): : 418 - 428
  • [8] Corilagin improves cognitive impairment in APP/PS1 mice by reducing An generation and enhancing synaptic plasticity
    Chen, Linyi
    Zhuang, Zhujun
    Duan, Hengqian
    Lv, Di
    Hong, Shengxiong
    Chen, Peng
    He, Bo
    Shen, Zhiqiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 981
  • [9] Galantamine attenuates amyloid-β deposition and astrocyte activation in APP/PS1 transgenic mice
    Wu, Zhaoxuan
    Zhao, Lingling
    Chen, Xinxin
    Cheng, Xiaoying
    Zhang, Yan
    EXPERIMENTAL GERONTOLOGY, 2015, 72 : 244 - 250
  • [10] Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice
    Lapeyre, Lina
    Piret, Jocelyne
    Rheaume, Chantal
    Pons, Vincent
    Uyar, Olus
    Prefontaine, Paul
    Rivest, Serge
    Boivin, Guy
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (01) : 171 - 178